PULVIRENTI, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 2.708
AS - Asia 1.745
EU - Europa 1.063
SA - Sud America 262
Continente sconosciuto - Info sul continente non disponibili 211
AF - Africa 89
OC - Oceania 14
Totale 6.092
Nazione #
US - Stati Uniti d'America 2.643
SG - Singapore 642
IT - Italia 517
VN - Vietnam 286
CN - Cina 261
HK - Hong Kong 197
BR - Brasile 196
IN - India 142
DE - Germania 118
BD - Bangladesh 100
FI - Finlandia 88
SE - Svezia 61
FR - Francia 54
RU - Federazione Russa 39
GB - Regno Unito 38
ZA - Sudafrica 37
CA - Canada 34
AR - Argentina 32
MA - Marocco 29
BG - Bulgaria 28
UA - Ucraina 22
ID - Indonesia 19
NL - Olanda 19
AT - Austria 15
TR - Turchia 15
AU - Australia 14
MX - Messico 14
JP - Giappone 13
ES - Italia 10
IQ - Iraq 10
RO - Romania 10
SA - Arabia Saudita 10
IE - Irlanda 9
PK - Pakistan 9
CI - Costa d'Avorio 8
CO - Colombia 8
KR - Corea 8
BE - Belgio 6
CL - Cile 6
PL - Polonia 6
PY - Paraguay 6
JM - Giamaica 5
LT - Lituania 5
PH - Filippine 5
TW - Taiwan 5
VE - Venezuela 5
KE - Kenya 4
UZ - Uzbekistan 4
DK - Danimarca 3
EG - Egitto 3
GY - Guiana 3
HU - Ungheria 3
JO - Giordania 3
MY - Malesia 3
TG - Togo 3
AL - Albania 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EC - Ecuador 2
LV - Lettonia 2
NG - Nigeria 2
NP - Nepal 2
PE - Perù 2
PS - Palestinian Territory 2
SV - El Salvador 2
TH - Thailandia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BH - Bahrain 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DM - Dominica 1
EE - Estonia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
SI - Slovenia 1
SN - Senegal 1
TT - Trinidad e Tobago 1
Totale 5.881
Città #
Singapore 343
Ashburn 339
Dallas 305
Fairfield 230
San Jose 213
Hong Kong 192
Rome 155
Ho Chi Minh City 100
Seattle 93
Los Angeles 88
Woodbridge 88
Chandler 86
Houston 84
Cambridge 74
Hanoi 63
Milan 62
Wilmington 59
Beijing 56
Santa Clara 52
Helsinki 51
Frankfurt am Main 39
Lauterbourg 39
New York 36
Munich 35
Hillsboro 33
Johannesburg 33
Princeton 32
Buffalo 29
Council Bluffs 28
Ann Arbor 26
Sofia 26
Boston 24
Casablanca 24
San Paolo di Civitate 24
Dearborn 23
Redondo Beach 22
Lawrence 21
Plano 21
The Dalles 19
San Diego 18
Cosenza 17
São Paulo 17
Haiphong 16
Naples 16
Jakarta 15
Toronto 15
Da Nang 14
Phoenix 14
Guangzhou 13
Millbury 13
Düsseldorf 12
Lappeenranta 12
Nuremberg 12
Rio de Janeiro 12
Turku 12
Chicago 11
Bengaluru 10
Moscow 10
Orem 10
Tokyo 10
Bari 9
Bologna 9
Dublin 9
Abidjan 8
Atlanta 8
Boardman 8
Hefei 8
Jacksonville 8
Pescara 8
Amsterdam 7
Biên Hòa 7
London 7
New Delhi 7
Norwalk 7
Shenzhen 7
Turin 7
Vienna 7
Brussels 6
Dhaka 6
Montreal 6
Ottawa 6
Selvazzano Dentro 6
Yubileyny 6
Can Tho 5
Curitiba 5
Falkenstein 5
Hải Dương 5
Istanbul 5
Mumbai 5
Newark 5
Ninh Bình 5
Tianjin 5
Warsaw 5
Andover 4
Brasília 4
Buenos Aires 4
Campinas 4
Charlotte 4
Chennai 4
Columbus 4
Totale 3.791
Nome #
Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022 313
Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality 209
Development and Initial Validation of a Questionnaire to Measure Health-Related Quality of Life of Adults with Common Variable Immune Deficiency: The CVID_QoL Questionnaire. 199
Hemolysis in patients with antibody deficiencies on immunoglobulin replacement treatment 190
Differential diagnosis in hypogammaglobulinemia 186
Assessment of vascular tortuosity in 22q11.2 deletion syndrome using optical coherence tomography angiography 171
Double-Blind, Placebo-Controlled Randomized Trial on Low Dose Azithromycin Prophilaxis in Primary Antibody Deficiencies 169
A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection 161
Gastric cancer is the leading cause of death in Italian adult patients with common variable immunodeficiency 153
Human herpesvirus-8–positive primary effusion lymphoma in HIV-negative patients: single institution case series with a multidisciplinary characterization 151
Covid-19, anosmia, and allergies. is there a relationship? a pediatric perspective 146
Lung magnetic resonance imaging with diffusion weighted imaging provides regional structural as well as functional information without radiation exposure in primary antibody deficiencies 146
Case report. interindividual variability and possible role of heterozygous variants in a family with deficiency of adenosine deaminase 2. are all heterozygous born equals 139
Idiopathic non cirrhotic portal hypertension and spleno-portal axis abnormalities in patients with severe primary antibody deficiencies. 138
Longitudinal study on health-related quality of life in a cohort of 96 patients with common variable immune deficiencies 135
Adequate Patient's Outcome Achieved with Short Immunoglobulin Replacement Intervals in Severe Antibody Deficiencies 132
Neuroinflammation and oxidative stress in individuals affected by DiGeorge syndrome 128
Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin therapy in complicated primary antibody deficiencies 123
Investigating psychiatric morbidity, hopelessness and suicide risk in patients with 22q11.2 deletion syndrome: a case-control study 119
Health-Related Quality of Life in Patients with CVID Under Different Schedules of Immunoglobulin Administration: Prospective Multicenter Study 119
Oropharyngeal microbial ecosystem perturbations influence the risk for acute respiratory infections in common variable immunodeficiency 118
Functional cvids phenotype clusters identified by the integration of immune parameters after bnt162b2 boosters 117
Phenotypic traits and family history in patients with 22q11.2 deletion syndrome and generalized epilepsy: A multicenter case–control study 116
Antibody-dependent Natural Killer (NK) cell activation and functions after recombinant Herpes Zoster (HZ) Vaccine in immunodeficient patients 114
Coexisting genetic findings in a cohort of patients with laboratory confirmation of 22q11.2 deletion syndrome 110
Serum free light chains in common variable immunodeficiency disorders: role in differential diagnosis and association with clinical phenotype 108
IGA antibody induced by immunization with pneumococcal polysaccharides is a prognostic tool in common variable immune deficiencies 106
Clinical Risk Factors for Aortic Root Dilation in Patients with 22q11.2 Deletion Syndrome: A Longitudinal Single-Center Study 102
Group A Streptococcus infections in children and adolescents in the post-COVID-19 era: a regional Italian survey 100
Clinical use of polyvalent immunoglobulins 97
Graft versus host disease 96
The olfactory function in patients with common variable immunodeficiency 93
Evaluation of the Benefit/Cost/Safety Profile of Low-dose Anti-CD20 Monoclonal Antibody (Rituximab) Treatment for Refractory Mixed Cryoglobulinemia 88
Risk factors for Haemophilus influenzae and pneumococcal respiratory tract colonization in CVID 87
Intravenous immunoglobulin replacement induces an in vivo reduction of inflammatory monocytes and retains the monocyte ability to respond to bacterial stimulation in patients with common variable immunodeficiencies 82
Pulmonary disease in primary immunodeficiency syndromes 82
Tailored therapies for primary immunodeficiencies 81
Efficacy and safety of clozapine in treatment-resistant psychotic patients with DiGeorge syndrome (22q11.2 deletion syndrome): a case series 78
Health-Related Quality of Life in Children and Adults with Primary Immunodeficiencies: A Systematic Review and Meta-analysis 78
The dilemma of X-linked agammaglobulinemia carriers 77
null 76
Pulmonary diseases in primary immunodeficiency syndromes 72
Salivary α‐Synuclein as a Candidate Biomarker of Parkinsonism in 22q11.2 Deletion Syndrome 71
Magnetic resonance with diffusion weighted imaging: A new method to detect active lung inflammation in patients with primary antibody deficiencies 71
Polyvalent immunoglobulins: challenges and perspectives. 70
null 68
Health-Related Quality of Life and Patients' Empowerment in the Health Care of Primary Immune Deficiencies 63
Hyper-IgE in the allergy clinic––when is it primary immunodeficiency? 57
null 52
null 51
null 46
Short-Term Side Effects and SARS-CoV-2 Infection after COVID-19 Pfizer–BioNTech Vaccine in Children Aged 5–11 Years: An Italian Real-World Study 45
Changes in health-related quality of life in common variable immunodeficiency: an eight-year journey, including the COVID-19 pandemic 44
null 44
Self-reported Clinical Outcomes and Quality of Life in Agammaglobulinemia: the Importance of an Early Diagnosis 41
Immunoglobulin-induced hemolysis, splenomegaly and inflammation in patients with antibody deficiencies. 40
Identification and functional study of a novel CTLA4 variant leads to targeted therapy with Abatacept in a case with complex phenotype and multiple monogenic conditions limiting conventional treatment 9
Identification and functional study of a novel CTLA4 variant leads to targeted therapy with Abatacept in a case with complex phenotype and multiple monogenic conditions limiting conventional treatment 7
The dilemma of X-linked agammaglobulinemia (XLA) carriers: multicenter, retrospective cohort study on the reproductive choices of XLA families 5
null 3
Totale 6.092
Categoria #
all - tutte 17.053
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.053


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022283 0 12 20 6 42 7 7 25 28 31 49 56
2022/2023334 57 68 15 22 52 33 7 18 35 4 10 13
2023/2024286 13 35 26 25 24 50 5 21 7 38 24 18
2024/20251.078 23 44 42 59 65 77 55 48 190 103 101 271
2025/20262.982 313 340 247 251 348 131 378 137 244 253 175 165
2026/2027220 161 59 0 0 0 0 0 0 0 0 0 0
Totale 6.092